Gales Ferry, CT, United States of America

Martha L Minich


Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Martha L. Minich

Introduction

Martha L. Minich is a prominent inventor based in Gales Ferry, CT (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. Her work focuses on developing compounds that address various medical conditions, showcasing her dedication to improving health outcomes.

Latest Patents

Among her latest patents, one notable invention is related to heterocyclo-alkylsulfonyl pyrazoles. This invention pertains to compounds that are useful in the treatment or alleviation of inflammation and other inflammation-associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, including humans, dogs, cats, and livestock animals. Another significant patent involves 5-heteroatom-substituted pyrazoles, which further expands her contributions to medicinal chemistry.

Career Highlights

Martha L. Minich has established herself as a key figure in the pharmaceutical industry, particularly through her work at Pfizer Corporation. Her innovative research and development efforts have led to advancements in therapeutic options for various diseases, demonstrating her commitment to enhancing patient care.

Collaborations

Martha has collaborated with notable colleagues, including Subas Man Sakya and Kristin M. Lundy. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in her field.

Conclusion

Martha L. Minich's contributions to pharmaceutical inventions highlight her role as a leading inventor in the industry. Her patents reflect her commitment to addressing critical health issues and improving the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…